» Articles » PMID: 29311260

MTOR Signaling in Stem and Progenitor Cells

Overview
Journal Development
Specialty Biology
Date 2018 Jan 10
PMID 29311260
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian target of rapamycin (mTOR) senses nutrients and growth factors to coordinate cell growth, metabolism and autophagy. Extensive research has mapped the signaling pathways regulated by mTOR that are involved in human diseases, such as cancer, and in diabetes and ageing. Recently, however, new studies have demonstrated important roles for mTOR in promoting the differentiation of adult stem cells, driving the growth and proliferation of stem and progenitor cells, and dictating the differentiation program of multipotent stem cell populations. Here, we review these advances, providing an overview of mTOR signaling and its role in murine and human stem and progenitor cells.

Citing Articles

Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment.

Tian R, Zhang R, Ma C Biomolecules. 2025; 15(2).

PMID: 40001580 PMC: 11853522. DOI: 10.3390/biom15020276.


PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitors.

DeSpenza Jr T, Kiziltug E, Allington G, Barson D, McGee S, OConnor D Nat Neurosci. 2025; 28(3):536-557.

PMID: 39994410 DOI: 10.1038/s41593-024-01865-3.


Dysregulation of mTOR signalling is a converging mechanism in lissencephaly.

Zhang C, Liang D, Ercan-Sencicek A, Bulut A, Cortes J, Cheng I Nature. 2025; 638(8049):172-181.

PMID: 39743596 PMC: 11798849. DOI: 10.1038/s41586-024-08341-9.


A CADASIL NOTCH3 mutation leads to clonal hematopoiesis and expansion of Dnmt3a-R878H hematopoietic clones.

Sanchez-Lanzas R, Barclay J, Hardas A, Kalampalika F, Jimenez-Pompa A, Gallipoli P Leukemia. 2024; 39(2):460-472.

PMID: 39537978 PMC: 11794143. DOI: 10.1038/s41375-024-02464-8.


A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice.

Mills T, Kain B, Burchill M, Danis E, Lucas E, Culp-Hill R Cell Stem Cell. 2024; 31(11):1630-1649.e8.

PMID: 39413777 PMC: 11560650. DOI: 10.1016/j.stem.2024.09.010.


References
1.
Phinney D, Prockop D . Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007; 25(11):2896-902. DOI: 10.1634/stemcells.2007-0637. View

2.
Huang J, Zhang Y, Bersenev A, OBrien W, Tong W, Emerson S . Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. J Clin Invest. 2009; 119(12):3519-29. PMC: 2786808. DOI: 10.1172/JCI40572. View

3.
Jung J, Kang K, Kim J, Hong S, Park Y, Kim B . CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities. Stem Cells Dev. 2016; 25(13):1006-19. PMC: 4931345. DOI: 10.1089/scd.2015.0395. View

4.
Salomoni P, Calegari F . Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol. 2010; 20(5):233-43. DOI: 10.1016/j.tcb.2010.01.006. View

5.
Smith A, Heath J, Donaldson D, Wong G, Moreau J, Stahl M . Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 1988; 336(6200):688-90. DOI: 10.1038/336688a0. View